Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 1817080 for diabetic neuropathic pain
2020-002066-14Phase 2Terminated
- Sponsor
- Bayer
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing BAY 1817080 with Placebo (2 arms). Started Sep 2020; status: terminated.
02
Drugs
eliapixant
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2020-002066-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002066-14.